Titan Pharmaceuticals (TTNP) Insider Trading & Ownership $4.48 -0.24 (-5.08%) Closing price 07/17/2025 04:00 PM EasternExtended Trading$4.58 +0.09 (+2.12%) As of 07/17/2025 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrendsBuy This Stock Titan Pharmaceuticals (NASDAQ:TTNP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.72%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$36.38KNumber OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$4.17M Get TTNP Insider Trade Alerts Want to know when executives and insiders are buying or selling Titan Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TTNP Insider Buying and Selling by Quarter Titan Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/21/2023David E. LazarCEOSell169,445$24.60$4,168,347.00 1/24/2023David E LazarCEOBuy1,875$19.40$36,375.00 (Data available from 1/1/2013 forward) TTNP Insider Trading Activity - Frequently Asked Questions Who is on Titan Pharmaceuticals' Insider Roster? The list of insiders at Titan Pharmaceuticals includes David E Lazar. Learn more on insiders at TTNP. What percentage of Titan Pharmaceuticals stock is owned by insiders? 0.72% of Titan Pharmaceuticals stock is owned by insiders. Learn more on TTNP's insider holdings. Titan Pharmaceuticals Key ExecutivesMr. David Elliot Lazar (Age 33)CEO & Principal Financial Officer Compensation: $1.42MDr. Katherine L. Beebe-DeVarney Ph.D. (Age 63)President, COO & Director Compensation: $462kMr. Mike FritzNational Sales DirectorJennifer KiernanExecutive Assistant to CEO & Investor Communications CoordinatorJoe SchreiExecutive Director of Commercial Operations More Insider Trading Tools from MarketBeat Related Companies Mannatech Insider Trades Athira Pharma Insider Trades Flora Growth Insider Trades Edesa Biotech Insider Trades Lexaria Bioscience Insider Trades HOOKIPA Pharma Insider Trades Ernexa Therapeutics Insider Trades Synlogic Insider Trades Bullfrog AI Insider Trades Briacell Therap Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional SupportDo They Know Something? Insiders & Congress Buy UnitedHealthMicron Insiders Sell But Investors Should Buy, Buy, Buy This page (NASDAQ:TTNP) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersElon Just Fired the IRS Agents Targeting Your SavingsElon Musk just fired 6,700 IRS agents — and exposed a war on your retirement. While D.C. scrambles to regai...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Titan Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Titan Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TTNP Stock Alerts